Lyons, Colorado
United States
22
2013-09-19
The entities that hold a legal rights for patent applications filed by inventor Wallace Eli:
Eli Wallace from Lyons, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Quinazoline analogs as receptor tyrosine kinase inhibitors
#2 | 2013-01-17HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF
#3 | 2010-03-116-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereof
#4 | 2009-10-29Quinazoline analogs as receptor tyrosine kinase inhibitors
#5 | 2009-08-276-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
#6 | 2009-02-19Quinazoline analogs as receptor tyrosine kinase inhibitors
#7 | 2009-01-08Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
#8 | 2008-11-13Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
#9 | 2008-08-14Quinazoline analogs as receptor tyrosine kinase inhibitors
#10 | 2006-08-24Heterocyclic inhibitors of MEK and methods of use thereof
#11 | 2006-08-24Method of treating hyperproliferative disorders using heterocyclic inhibitors of MEK
#12 | 2006-08-24Heterocyclic inhibitors of MEK and methods of use thereof
#13 | 2005-11-17Heterocyclic inhibitors of MEK and methods of use thereof
#14 | 2005-11-10Heterocyclic inhibitors of MEK and methods of use thereof
#15 | 2005-07-14Heterocyclic inhibitors of MEK and methods of use thereof
#16 | 2005-06-16Bicyclic inhibitors of MEK and methods of use thereof
#17 | 2005-06-16Bicyclic inhibitors of MEK and methods of use thereof
#18 | 2005-05-12Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
#19 | 2005-05-12Quinazoline analogs as receptor tyrosine kinase inhibitors
#20 | 2005-03-10Heterocyclic inhibitors of MEK and methods of use thereof
#21 | 2005-03-03Heterocyclic inhibitors of MEK and methods of use thereof
#22 | 2005-02-24Quinazoline analogs as receptor tyrosine kinase inhibitors
42591 ⎘